半岛bd体育手机客户端 说明
生化/生理作用
KIRA8 is an ATP-competitive, potent and selective IRE1α kinase inhibitor (IRE1α/β Ki= 2/120 nM) that attenuates IRE1α endonuclease activity (IRE1α/β IC50= 5/55 nM) with good kinome selectivity. KIRA8 inhibits thapsigargin-induced UPR (IC50= 99 nM; HT1080 XBP1-Luc cells) and shows therapeutic efficacy in murine models of type 1 diabetes (T1D), pulmonary fibrosis, multiple myeloma (MM), and pancreatic neuroendocrine tumors (PanNET)in vivo(30-50 mg/kg/day i.p.).
基本信息
经验(实验)分子式 | C31H29ClN6O3S |
分子量 | 601.12 |
MDL编号 | MFCD28404657 |
半岛bd体育手机客户端 性质
质量水平 | 100 |
测定 | ≥98% (HPLC) |
形式 | powder |
颜色 | white to beige |
溶解性 | DMSO: 2 mg/mL, clear |
储存温度 | 2-8℃ |
安全信息
储存分类代码 | 11 - Combustible Solids |
WGK | WGK 3 |
Sigma-Aldrich